title: Regression of a basal cell carcinoma infiltrating the brain after vismodegib therapy.
authors.affiliation: Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
authors.forename: Katharina C
authors.initials: KC
authors.lastname: Kaehler
authors.forename: Ralf
authors.initials: R
authors.lastname: Gutzmer
authors.forename: Friederike
authors.initials: F
authors.lastname: Egberts
authors.forename: Axel
authors.initials: A
authors.lastname: Hauschild
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000813:Anilides / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology*; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology*; D005153:Facial Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009361:Neoplasm Invasiveness; D011725:Pyridines / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; C538724:HhAntag691; D011725:Pyridines